Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals KNOXVILLE, TN / ACCESSWIRE / December 10, 2024 / VisiRose, a ...
Merakris Therapeutics is pleased to announce that enrollment is now open for Part 2 of its Phase 2 multicenter, clinical trial (NCT04647240) of its investigational wound care drug, Dermacyte ® ...